Iron-acrylic compound for steriotaxic aneurysm thrombosis.
A new iron-acrylic compound has been developed for stereotaxic thrombosis of intracranial aneurysms. The compound polymerizes rapidly, does not fragment, and is nontoxic. It has been used in a series of experimental animals and in initial clinical cases with good results. The use of this material simplifies and increases the safety of stereotaxic aneurysm treatment.
D000818:Animals; D004285:Dogs; D004621:Embolization, Therapeutic / Q000379:methods*; D006801:Humans; D002532:Intracranial Aneurysm / Q000628:therapy*; D007501:Iron / Q000627:therapeutic use*; D008280:Magnetics; D008297:Male; D008768:Methylmethacrylates / Q000627:therapeutic use*; D013238:Stereotaxic Techniques
D008768:Methylmethacrylates; D007501:Iron